The "Growth Opportunities in Biologics Contract Development and Manufacturing Organizations, 2024-2029" report has been added to ResearchAndMarkets.com's offering. This analysis provides detailed ...
CDMO ProBio, the biologics subsidiary of GenScript, expanded its plasmid DNA and viral vector production capacity with the opening of new manufacturing facility in Hopewell, New Jersey. The site, ...
As more cell, gene and immunotherapy applications emerge for lentiviral vectors, demand for their production continues to rise. With its move last week into a larger manufacturing facility, CDMO ...
"The combination of existing projects and new ones expected to be added before the end of the year will generate a total revenue, as previously guided, between $4 million and $6 million." (CEO Rakib) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results